Justin Meiklem

Vancouver, British Columbia and Rehovot, Israel – May 1, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, May 2nd to discuss recently announced milestone achievements, including full year 2023 […]

Vancouver, British Columbia and Rehovot, Israel – April 16, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced the signing of two agreements: a long term lease agreement  for a new 80,000 square ft. facility  in Yavne, Israel, and an

Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel – March 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of experienced life sciences executive